Commentary: Estimation of vaccine effectiveness using the screening method.
作者信息
Flannery Brendan, Andrews Nick, Feikin Daniel, Patel Minal K
机构信息
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
United Kingdom Health Security Agency, London, UK.
出版信息
Int J Epidemiol. 2023 Feb 8;52(1):19-21. doi: 10.1093/ije/dyac013.
Abstract
摘要
相似文献
1
Commentary: Estimation of vaccine effectiveness using the screening method.评论：使用筛查方法评估疫苗效力
Int J Epidemiol. 2023 Feb 8;52(1):19-21. doi: 10.1093/ije/dyac013.
2
Estimation of vaccine effectiveness using the screening method.利用筛查法估计疫苗效力。
Int J Epidemiol. 2023 Feb 8;52(1):14-21. doi: 10.1093/ije/dyac207.
3
Estimation of COVID-19 vaccine effectiveness against infections and severe outcomes using routine surveillance data in Kosovo, July-September 2021.利用 2021 年 7 月至 9 月科索沃常规监测数据估计 COVID-19 疫苗对感染和重症结局的有效性。
PLoS One. 2024 Jul 24;19(7):e0305629. doi: 10.1371/journal.pone.0305629. eCollection 2024.
4
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.利用随机试验数据评估COVID-19疫苗有效性的检测阴性设计：5项随机临床试验的二次交叉方案分析
JAMA Netw Open. 2025 May 1;8(5):e2512763. doi: 10.1001/jamanetworkopen.2025.12763.
5
The use of the screening technique as a method of rapidly estimating vaccine efficacy.将筛查技术用作快速评估疫苗效力的一种方法。
Public Health. 1990 Jan;104(1):21-5. doi: 10.1016/s0033-3506(05)80341-5.
6
Fast COVID-19 vaccine effectiveness estimation on the basis of recovered individual propensity to be vaccinated.基于康复个体接种疫苗倾向的快速新冠疫苗有效性评估。
Public Health. 2022 Apr;205:e6-e7. doi: 10.1016/j.puhe.2021.10.014. Epub 2021 Nov 9.
7
Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics.从多变异体流行疫情的人群水平监测数据估计疫苗效力衰减情况。
Epidemics. 2023 Dec;45:100726. doi: 10.1016/j.epidem.2023.100726. Epub 2023 Nov 4.
8
Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy.四组分重组蛋白疫苗对意大利 B 群脑膜炎球菌病的有效性。
JAMA Netw Open. 2023 Aug 1;6(8):e2329678. doi: 10.1001/jamanetworkopen.2023.29678.
9
Application of the screening method for estimating COVID-19 vaccine effectiveness using routine surveillance data: Germany's experience during the COVID-19 pandemic, July 2021 to March 2023.应用常规监测数据估算 COVID-19 疫苗有效性的筛选方法：德国在 2021 年 7 月至 2023 年 3 月期间的 COVID-19 大流行期间的经验。
Euro Surveill. 2024 Feb;29(8). doi: 10.2807/1560-7917.ES.2023.29.8.2300329.
10
Estimation of vaccine effectiveness using the screening method.使用筛查方法评估疫苗效力。
Int J Epidemiol. 1993 Aug;22(4):742-6. doi: 10.1093/ije/22.4.742.
引用本文的文献
1
Assessing the Impact of Nirsevimab Immunization on RSV Bronchiolitis Hospital Admissions and Their Severity: A Case-Control Study and Comparison With Pre- and Post-COVID-19 Seasons in a Tertiary Pediatric Hospital.评估尼塞韦单抗免疫接种对呼吸道合胞病毒细支气管炎住院率及其严重程度的影响：一项病例对照研究，并与一家三级儿科医院在新冠疫情前和后的季节进行比较。
Pediatr Pulmonol. 2025 Jul;60(7):e71059. doi: 10.1002/ppul.71059.
2
Mpox Epidemiology and Vaccine Effectiveness, England, 2023.2023 年英格兰猴痘的流行病学和疫苗效力。
Emerg Infect Dis. 2024 Oct;30(10):2145-2148. doi: 10.3201/eid3010.240292. Epub 2024 Sep 11.
3
Long-Term Protective Immunity against Infection Induced by a Genetically Modified Live Vaccine.基因工程减毒活疫苗诱导的针对感染的长期保护性免疫
Vaccines (Basel). 2024 Aug 9;12(8):903. doi: 10.3390/vaccines12080903.
4
Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023.2022 年和 2023 年荷兰猴痘疫情下降的潜在因素。
Euro Surveill. 2024 May;29(21). doi: 10.2807/1560-7917.ES.2024.29.21.2300608.
5
Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol.评价澳大利亚北领地和南澳大利亚地区脑膜炎 B 型疫苗（4CMenB）针对淋病感染的持久有效性的全面观察性研究：研究方案。
BMJ Open. 2024 May 8;14(5):e079144. doi: 10.1136/bmjopen-2023-079144.
6
A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022.一项综合横断面分析和病例对照研究，评估2005年至2022年瑞士儿童和青少年的蜱传脑炎疫苗接种覆盖率、疾病及疫苗有效性。
Euro Surveill. 2024 May;29(18). doi: 10.2807/1560-7917.ES.2024.29.18.2300558.
Zotero 插件